114 related articles for article (PubMed ID: 30481877)
21. [Hepatogenic diabetes].
Perseghin G; Caloni M; Mazzaferro V; Luzi L
Recenti Prog Med; 2001 Dec; 92(12):757-61. PubMed ID: 11822099
[TBL] [Abstract][Full Text] [Related]
22. Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants.
Pais R; Lebray P; Rousseau G; Charlotte F; Esselma G; Savier E; Thabut D; Rudler M; Eyraud D; Vezinet C; Siksik JM; Vaillant JC; Hannoun L; Poynard T; Ratziu V
Clin Gastroenterol Hepatol; 2015 May; 13(5):992-9.e2. PubMed ID: 25459558
[TBL] [Abstract][Full Text] [Related]
23. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
[TBL] [Abstract][Full Text] [Related]
24. Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome.
Kasmari AJ; Welch A; Liu G; Leslie D; McGarrity T; Riley T
Am J Med; 2017 Jun; 130(6):746.e1-746.e7. PubMed ID: 28109969
[TBL] [Abstract][Full Text] [Related]
25. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
Lai MS; Hsieh MS; Chiu YH; Chen TH
Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
[TBL] [Abstract][Full Text] [Related]
26. Obesity-associated mechanisms of hepatocarcinogenesis.
Karagozian R; Derdák Z; Baffy G
Metabolism; 2014 May; 63(5):607-17. PubMed ID: 24629562
[TBL] [Abstract][Full Text] [Related]
27. Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver function.
Kołodziejski PA; Pruszyńska-Oszmałek E; Strowski MZ; Nowak KW
Endocrine; 2017 Jun; 56(3):538-550. PubMed ID: 28477305
[TBL] [Abstract][Full Text] [Related]
28. Effect of hyperglycemia on hepatocellular carcinoma development in diabetes.
Niwa Y; Ishikawa K; Ishigami M; Honda T; Achiwa K; Izumoto T; Maekawa R; Hosokawa K; Iida A; Seino Y; Hamada Y; Goto H; Oiso Y; Arima H; Tsunekawa S
Biochem Biophys Res Commun; 2015 Jul; 463(3):344-50. PubMed ID: 26022129
[TBL] [Abstract][Full Text] [Related]
29. Diabetes is not an independent risk factor for hepatocellular carcinoma.
Tseng CH
Diabetes Metab Res Rev; 2013 Oct; 29(7):515-24. PubMed ID: 23658071
[TBL] [Abstract][Full Text] [Related]
30. Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes--National cohort of Taiwan Diabetes Study.
Li CI; Chen HJ; Lai HC; Liu CS; Lin WY; Li TC; Lin CC
Int J Cancer; 2015 Jun; 136(11):2668-79. PubMed ID: 25387451
[TBL] [Abstract][Full Text] [Related]
31. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.
Orikasa H; Ohyama R; Tsuka N; Eyden BP; Yamazaki K
J Submicrosc Cytol Pathol; 2001; 33(1-2):195-200. PubMed ID: 11686402
[TBL] [Abstract][Full Text] [Related]
32. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract][Full Text] [Related]
33. Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus.
Donadon V; Balbi M; Zanette G
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):465-7. PubMed ID: 19817667
[No Abstract] [Full Text] [Related]
34. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
[TBL] [Abstract][Full Text] [Related]
35. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma.
Cervello M; Augello G; Cusimano A; Emma MR; Balasus D; Azzolina A; McCubrey JA; Montalto G
Adv Biol Regul; 2017 Aug; 65():59-76. PubMed ID: 28619606
[TBL] [Abstract][Full Text] [Related]
36. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.
Desbois AC; Cacoub P
World J Gastroenterol; 2017 Mar; 23(9):1697-1711. PubMed ID: 28321170
[TBL] [Abstract][Full Text] [Related]
37. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
Vaag A
Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
[TBL] [Abstract][Full Text] [Related]
38. Glucose intolerance and hepatocellular carcinoma: recent findings for old diseases.
Facciorusso A; Barone M
Hepatobiliary Surg Nutr; 2014 Apr; 3(2):91-2. PubMed ID: 24812601
[TBL] [Abstract][Full Text] [Related]
39. Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection.
Chan KM; Kuo CF; Hsu JT; Chiou MJ; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Lee WC
Liver Int; 2017 Mar; 37(3):434-441. PubMed ID: 27775209
[TBL] [Abstract][Full Text] [Related]
40. Steatosis and hepatocellular carcinoma risk.
Smedile A; Bugianesi E
Eur Rev Med Pharmacol Sci; 2005; 9(5):291-3. PubMed ID: 16231592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
